P203 VEDOLIZUMAB IS SAFE AFTER ANTI-TNF-ASSOCIATED PULMONARY TUBERCULOSIS IN CROHN’S DISEASE: CASE REPORT

Authors :: Muhammad B. Hammami
Christine Hachem
Pratik Pandit
Omar Sallam
Mary S. Burton
Source :: Inflammatory Bowel Diseases. 24:S80-S80
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: Crohn's disease
medicine.medical_specialty
Tuberculosis
Hepatology
business.industry
Gastroenterology
Mucous membrane
medicine.disease
Vedolizumab
medicine.anatomical_structure
Pulmonary tuberculosis
Internal medicine
Adalimumab
Medicine
Immunology and Allergy
Tumor necrosis factor alpha
business
Lung cancer
medicine.drug

Full Text Access

Tools